Enzo Biochem, Inc. Announces Issuance of United States Patent for Advanced Nucleic Acid Hybridization Probe Technology for Clinical and Research Applications
Enzo Biochem, Inc. ($0.01 Par Value) (ENZ)
Last enzo biochem, inc. ($0.01 par value) earnings: 12/7 04:10 pm
Check Earnings Report
US:NYSE Investor Relations:
enzo.com/corporate/investor-information
Company Research
Source: Business Wire
Transformative Development in Diagnostic Testing, Drug Development and Academic Research Marketplace Provides a Simple, Cost Effective and Scalable ProcessNew Probe Technology Advances Company’s Ability to Offer Lower-Cost High-Performance Products and Services in the Clinical Diagnostics Market NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ), an integrated diagnostics and therapeutics company, today announced the issuance of U.S. Patent No. 10,323,272 entitled Nucleic Acid Probes for In Situ Hybridization. The patent is related to a new probe technology developed by Enzo and transformative methods of testing using the probes, which allow for significantly more cost effective, simple and scalable processes across the multi-billion dollar diagnostic testing, drug development and academic research marketplace.These new probes can be used to detect clinically relevant genomic targets with high-sensitivity in cell samples and biopsy tissue obtained from patients. Significantly
Show less
Read more
Impact Snapshot
Event Time:
ENZ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ENZ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ENZ alerts
High impacting Enzo Biochem, Inc. ($0.01 Par Value) news events
Weekly update
A roundup of the hottest topics
ENZ
News
- Enzo Biochem, Inc. (NYSE: ENZ) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Enzo Biochem, Inc. (NYSE: ENZ) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Enzo Biochem, Inc. (NYSE: ENZ) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Enzo Biochem Reports Fourth Quarter and Fiscal Year 2024 Results and Announces Cash DividendGlobeNewswire
- Enzo Biochem, Inc. (NYSE: ENZ) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
ENZ
Sec Filings
- 10/30/24 - Form 8-K
- 10/29/24 - Form 10-K
- 9/24/24 - Form 8-K
- ENZ's page on the SEC website